MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
INmune Bio Inc. Common stock

INMB

#3602
INmune Bio Inc. Common stock
1.29
-3.01%
Sector:
Base:
Profit Currency:
Daily Range
1.29
1.29
Year Range
1.21
11.64
Daily Change
-3.01%
Monthly Change
-27.93%
6 month change
-37.68%
Year Change
-83.18%
Previous Close
1.33
Open
1.29
Bid
Ask
Low
1.29
High
1.29
Volume
24
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. INMB
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Seeking Alpha Seeking Alpha
INMB
yesterday, 05:07
INmune Bio Inc. (INMB) Discusses MissionEB Phase III Trial and CORDStrom as a Disease-Modifying Therapy for RDEB Transcript
Investing Investing
INMB
2026.02.19
INmune Bio to host webinar on RDEB treatment data
Investing Investing
INMB
2026.01.27
INmune Bio outlines 2025 progress on Alzheimer’s and RDEB therapies
Investing Investing
INMB
2025.12.01
INmune Bio stock falls after new Alzheimer’s trial data
Investing Investing
INMB
2025.12.01
INmune Bio reports promising Alzheimer’s drug data at CTAD conference
Investing Investing
INMB
2025.11.28
Inmune Bio announces new executive employment agreements with compensation details
Zacks Zacks
INMB
2025.11.06
INmune Bio (INMB) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Seeking Alpha Seeking Alpha
INMB
2025.10.31
INmune Bio, Inc. (INMB) Q3 2025 Earnings Call Transcript
Investing Investing
INMB
2025.09.29
INmune Bio submits manuscript on Phase 2 Alzheimer’s trial results
Zacks Zacks
INMB
2025.09.08
INmune Bio (INMB) Loses 23.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Investing Investing
INMB
2025.08.08
INmune Bio August 2025 slides: three-platform strategy shows clinical progress
The Motley Fool The Motley Fool
INMB
2025.08.07
INmune Bio (INMB) Q2 Loss Widens 110%

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd